(NYSE: CTLT), the leading global provider of development sciences and manufacturing platforms for medicines, including biotherapeutics cell and gene therapies and consumer health products, today announced that it has reached an agreement to acquire Bettera Holdings, LLC, a major manufacturer in the high-growth gummy, soft chew, and lozenge segments of the nutritional supplements market, for $1 billion, subject to customary adjustments.
0 Comments
Leave a Reply. |